Company: CRVO
Filing Date: 2025-03-17
Form Type: 10-K
Source: 0001437749-25-007829
Chunk: 95

Company: CervoMed Inc.
Filing Date: 2025-03-17
Form: 10-K
Item: Item 1A
Chunk 95
---
. There would likely also be a decline in the liquidity of the trading market for the Company’s common stock and a reduction in the Company’s coverage by securities analysts and the news media, which could cause the price of the Company’s common stock to decline further.

69

Provisions in the Company’ s corporate charter documents and under Delaware law could make an acquisition of the Company, which may be beneficial to the Company’ s stockholders, more difficult and may prevent attempts by the Company’ s stockholders to replace or remove its current directors and members of management.

Provisions in the Company’s certificate of incorporation, as amended, and its amended and restated bylaws may discourage, delay or prevent a merger, acquisition or other change in control of the Company that stockholders may consider favorable, including transactions in which the Company’s stockholders might otherwise receive a premium for their shares. These provisions could also limit the price that investors are willing to pay in the future for shares of the Company’s common stock, thereby depressing the market price of its common stock. In addition, because the Board is responsible for appointing the members of its management team, these provisions may frustrate or prevent any attempts by the Company’s stockholders to replace or remove its current management by making it more difficult for stockholders to replace members of the Board. Among other things, these provisions:

  allow the authorized number of the Company’s directors to be changed only by resolution of the Board;  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────

  limit the manner in which stockholders can remove directors from the Board;  

  establish advance notice requirements for stockholder proposals that can be acted on at stockholder meetings and nominations to the Board;  

  limit who may call stockholder meetings and the Company stockholders’ ability to act by written consent;  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────

  authorize the Board to issue preferred stock without stockholder approval, which could be used to institute a “poison pill” that would work to dilute the stock ownership of a potential hostile ...  

  require the approval of the holders of at least 2/3 of the votes that all the Company’s stockholders would be entitled to cast to amend or repeal specified provisions of the Company’s certifica...  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

Moreover, because the Company is incorporated